Suppr超能文献

RAD51基因多态性与乳腺癌易感性的关联:一项荟萃分析。

Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

作者信息

Li Wei, Liu Ke-Jia, Song Jing-Song, Song Rui, Liu Zi-Liang

机构信息

Department of Oncology, The First Peoples Hospital of Tianmen City Tianmen 431700, Hubei Province, China.

Department of Cardiothoracic Surgery, The First Peoples Hospital of Tianmen City Tianmen 431700, Hubei Province, China.

出版信息

Int J Clin Exp Med. 2015 Feb 15;8(2):2326-33. eCollection 2015.

Abstract

BACKGROUND

RAD51 interacting with BRCA1 and BRCA2 could modulate the penetrance of BRCA1/BRCA2 mutations, which may increase susceptibility for breast cancer by inhibiting DNA repair and genome stability. The purpose of this study was to provide refined statistical evidence for the association between RAD51 polymorphism and breast cancer risk.

DESIGN AND RESULTS

We conducted a meta-analysis of 15 publications with a total of 11,766 cancer cases and 11,227 controls. We summarized the data on the association of RAD51 polymorphism with breast cancer risk and performed subgroup analyses by ethnicity and control source. The pooled ORs based on fixed-effects model did not indicate a modified risk of breast cancer associated with RAD51 polymorphism in the overall population. Nor did we find a significant association in any stratified analysis.

CONCLUSIONS

This meta-analysis suggested that RAD51 polymorphism did not appear to represent a significant risk factor for breast cancer.

摘要

背景

RAD51与BRCA1和BRCA2相互作用可调节BRCA1/BRCA2突变的外显率,这可能通过抑制DNA修复和基因组稳定性增加患乳腺癌的易感性。本研究的目的是为RAD51基因多态性与乳腺癌风险之间的关联提供更精确的统计学证据。

设计与结果

我们对15篇文献进行了荟萃分析,共纳入11766例癌症病例和11227例对照。我们总结了RAD51基因多态性与乳腺癌风险关联的数据,并按种族和对照来源进行了亚组分析。基于固定效应模型的合并比值比未表明RAD51基因多态性与总体人群中乳腺癌风险的改变有关。我们在任何分层分析中也未发现显著关联。

结论

这项荟萃分析表明,RAD51基因多态性似乎不是乳腺癌的显著危险因素。

相似文献

1
Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.
Int J Clin Exp Med. 2015 Feb 15;8(2):2326-33. eCollection 2015.
2
Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.
PLoS One. 2013 Sep 9;8(9):e75153. doi: 10.1371/journal.pone.0075153. eCollection 2013.
4
RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
Cancer Genet Cytogenet. 2007 Oct 1;178(1):65-9. doi: 10.1016/j.cancergencyto.2007.05.024.
5
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Breast Cancer Res Treat. 2011 Feb;125(3):827-35. doi: 10.1007/s10549-010-0995-8. Epub 2010 Jul 17.
6
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
Mol Med Rep. 2011 Sep-Oct;4(5):901-12. doi: 10.3892/mmr.2011.523. Epub 2011 Jul 1.
7
Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
Breast Cancer. 2017 Mar;24(2):229-237. doi: 10.1007/s12282-016-0692-5. Epub 2016 Apr 11.
8
Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
Pathol Int. 2008 May;58(5):275-81. doi: 10.1111/j.1440-1827.2008.02223.x.
9
Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.
Carcinogenesis. 2009 Jan;30(1):43-9. doi: 10.1093/carcin/bgn233. Epub 2008 Oct 28.

引用本文的文献

1
Clinical and genetic characterization of hereditary breast cancer in a Chinese population.
Hered Cancer Clin Pract. 2017 Oct 30;15:19. doi: 10.1186/s13053-017-0079-4. eCollection 2017.

本文引用的文献

1
RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women.
Pol J Pathol. 2013 Apr;64(1):39-43. doi: 10.5114/pjp.2013.34602.
2
RAD51 polymorphisms and breast cancer risk.
Mol Biol Rep. 2013 Jan;40(1):665-8. doi: 10.1007/s11033-012-2105-y. Epub 2012 Oct 13.
3
Disparities in breast cancer mortality trends in a middle income country.
Breast Cancer Res Treat. 2012 Aug;134(3):1199-207. doi: 10.1007/s10549-012-2026-4. Epub 2012 Mar 30.
4
Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk.
Breast Cancer Res Treat. 2011 Sep;129(2):649-51; author reply 652-3. doi: 10.1007/s10549-011-1537-8. Epub 2011 May 3.
5
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Breast Cancer Res Treat. 2011 Feb;125(3):827-35. doi: 10.1007/s10549-010-0995-8. Epub 2010 Jul 17.
6
RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.
Breast Cancer Res Treat. 2011 Jan;125(2):529-35. doi: 10.1007/s10549-010-1031-8. Epub 2010 Jul 11.
7
RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.
Breast Cancer Res Treat. 2011 Apr;126(2):365-71. doi: 10.1007/s10549-010-0937-5. Epub 2010 May 12.
8
RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects.
Breast Cancer Res Treat. 2011 Jan;125(1):157-61. doi: 10.1007/s10549-010-0922-z. Epub 2010 May 8.
9
RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Breast Cancer Res Treat. 2010 Dec;124(3):765-9. doi: 10.1007/s10549-010-0885-0. Epub 2010 Apr 16.
10
ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.
Mol Biol Rep. 2011 Jan;38(1):343-8. doi: 10.1007/s11033-010-0113-3. Epub 2010 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验